Acadia redesigns study on Parkinson's psychosis drug

(Reuters) - Acadia Pharmaceuticals Inc said it redesigned an ongoing late-stage study on its experimental anti-psychotic drug for Parkinson's disease patients, and that it plans to conduct an...

donate car massachusetts